Search - tctmd.com

Displaying 1 - 3 of 3

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

Presentation TCT 2013

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Presenter: Nicolas DUMONTEIL, Alaide Chieffo, Didier Tchetche, Nicolas Van Mieghem, Bertrand Marcheix, Robert M A Van Der Boon, Gill Buchanan, Olivier Vahdat, Patrick Serruys, Jean Fajadet, Peter De Jaegere, Antonio Colombo, Didier Carri?

January 31, 2013

Presentation TCT 2012

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Presenter: Giulio G. Stefanini, Bindu Kalesan, Lorenz Raber, Thomas Pilgrim, Yoshinobu Onuma, Sigmund Silber, Patrick W. Serruys, Bernhard Meier, Peter Juni, Stephan Windecker

January 03, 2012

Advertisement

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Impact of pre-operative chronic kidney disease on transcatheter aortic valve implantation outcome

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content